ATLANTA, GA — Georgia’s Republican Governor Brian Kemp signed legislation into law today to facilitate regulations governing the licensed production and distribution of oils and other products containing limited amounts of plant-derived THC.
House Bill 324 (aka Georgia’s Hope Act) establishes a regulatory commission to oversee the eventual “production, manufacturing, and dispensing” of products possessing specified quantities of plant-derived THC to qualified patients.
The law allows for the licensing of up to six cultivation operations, and seeks collaboration with the University of Georgia in the manufacturing of THC-infused extracts and oils.
Under a 2015 state law, qualified patients are exempt from criminal prosecution for the possession of oil extracts containing not more than 5 percent THC and an amount of CBD equal to or greater than the amount of THC.
However, the law failed to provide any mechanism for patients to obtain low-THC products from a state-regulated producer or provider.
Approximately 9,500 patients are currently registered with the state to possess medical cannabis products.